Search research articles
Contact Us
Filters
Showing results (411-420 of 469) with videos related to
Page
of 47
Sort By:
Liver Cancer
|
August 20, 2021
Downstaging and Resection of Initially Unresectable Hepatocellular Carcinoma with Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody Combinations
Xiao-Dong Zhu, Cheng Huang, Ying-Hao Shen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
April 30, 2025
CXCL6 Reshapes Lipid Metabolism and Induces Neutrophil Extracellular Trap Formation in Cholangiocarcinoma Progression and Immunotherapy Resistance
Tian He, Zi-Yi Wang, Bin Xu, et al.
Plos One
|
February 15, 2013
Suppression of natural killer cells by sorafenib contributes to prometastatic effects in hepatocellular carcinoma
Qiang-Bo Zhang, Hui-Chuan Sun, Ke-Zhi Zhang, et al.
World Journal of Surgery
|
August 15, 2012
Clinical experience with primary hepatic epithelioid hemangioendothelioma: retrospective study of 33 patients
Long-Rong Wang, Jia-Min Zhou, Yi-Ming Zhao, et al.
Neurocritical Care
|
March 29, 2020
Intraventricular Hemorrhage Growth: Definition, Prevalence and Association with Hematoma Expansion and Prognosis
Qi Li, Rui Li, Li-Bo Zhao, et al.
Frontiers in Oncology
|
May 13, 2025
Efficacy and safety of combined targeted therapy and immunotherapy versus targeted monotherapy in older patients with uHCC
Yu Li, Jian-Hong Zhong, Xiao-Dong Zhu, et al.
Cancer Science
|
May 9, 2019
Lymphoid-specific helicase promotes the growth and invasion of hepatocellular carcinoma by transcriptional regulation of centromere protein F expression
Xuan Yang, Bi-Si Miao, Chuan-Yuan Wei, et al.
Plos One
|
November 7, 2013
MicroRNA-26a inhibits angiogenesis by down-regulating VEGFA through the PIK3C2α/Akt/HIF-1α pathway in hepatocellular carcinoma
Zong-Tao Chai, Jian Kong, Xiao-Dong Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 3, 2005
FTY720: a promising agent for treatment of metastatic hepatocellular carcinoma
Terence K Lee, Kwan Man, Joanna W Ho, et al.
BMC Medicine
|
October 22, 2025
Anti-PD1 antibody toripalimab combined with lenvatinib, or GEMOX chemotherapy combined with lenvatinib as first-line therapy in patients with advanced intrahepatic cholangiocarcinoma: a randomized, open, two-cohort Phase 2 Study
Xiao-Yong Huang, Guo-Ming Shi, Zhi-Tao Zheng, et al.
Page
of 47
Search research articles
Search
Showing results (411-420 of 469) with videos related to
Sort By:
Page
of 47
Liver Cancer
|
August 20, 2021
Downstaging and Resection of Initially Unresectable Hepatocellular Carcinoma with Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody Combinations
Xiao-Dong Zhu, Cheng Huang, Ying-Hao Shen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
April 30, 2025
CXCL6 Reshapes Lipid Metabolism and Induces Neutrophil Extracellular Trap Formation in Cholangiocarcinoma Progression and Immunotherapy Resistance
Tian He, Zi-Yi Wang, Bin Xu, et al.
Plos One
|
February 15, 2013
Suppression of natural killer cells by sorafenib contributes to prometastatic effects in hepatocellular carcinoma
Qiang-Bo Zhang, Hui-Chuan Sun, Ke-Zhi Zhang, et al.
World Journal of Surgery
|
August 15, 2012
Clinical experience with primary hepatic epithelioid hemangioendothelioma: retrospective study of 33 patients
Long-Rong Wang, Jia-Min Zhou, Yi-Ming Zhao, et al.
Neurocritical Care
|
March 29, 2020
Intraventricular Hemorrhage Growth: Definition, Prevalence and Association with Hematoma Expansion and Prognosis
Qi Li, Rui Li, Li-Bo Zhao, et al.
Frontiers in Oncology
|
May 13, 2025
Efficacy and safety of combined targeted therapy and immunotherapy versus targeted monotherapy in older patients with uHCC
Yu Li, Jian-Hong Zhong, Xiao-Dong Zhu, et al.
Cancer Science
|
May 9, 2019
Lymphoid-specific helicase promotes the growth and invasion of hepatocellular carcinoma by transcriptional regulation of centromere protein F expression
Xuan Yang, Bi-Si Miao, Chuan-Yuan Wei, et al.
Plos One
|
November 7, 2013
MicroRNA-26a inhibits angiogenesis by down-regulating VEGFA through the PIK3C2α/Akt/HIF-1α pathway in hepatocellular carcinoma
Zong-Tao Chai, Jian Kong, Xiao-Dong Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 3, 2005
FTY720: a promising agent for treatment of metastatic hepatocellular carcinoma
Terence K Lee, Kwan Man, Joanna W Ho, et al.
BMC Medicine
|
October 22, 2025
Anti-PD1 antibody toripalimab combined with lenvatinib, or GEMOX chemotherapy combined with lenvatinib as first-line therapy in patients with advanced intrahepatic cholangiocarcinoma: a randomized, open, two-cohort Phase 2 Study
Xiao-Yong Huang, Guo-Ming Shi, Zhi-Tao Zheng, et al.
Page
of 47